6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺
6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺
6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺 性质
沸点 | 617.4±65.0 °C(Predicted) |
---|---|
密度 | 1.47±0.1 g/cm3(Predicted) |
储存条件 | 2-8°C(protect from light) |
溶解度 | DMF: 30 mg/mL,DMSO: 30 mg/mL,DMSO:PBS(pH7.2) (1:1): 0.5 mg/mL,乙醇: 25 mg/mL |
形态 | 粉末 |
酸度系数(pKa) | 10.15±0.29(Predicted) |
6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺 用途与合成方法
GRP94 0.22 μM (EC 50 ) |
HSP90α 27.3 μM (EC 50 ) |
HSP90β 41.8 μM (EC 50 ) |
TRAP-1 7.3 μM (EC 50 ) |
PU-WS13 is a Grp94 inhibitor, with an EC 50 of 0.22 μM. PU-WS13 also slightly suppresses Hsp90α, Hsp90β and Trap-1, with EC 50 s of 27.3, 41.8 and 7.3 μM, respectively. PU-WS13 (2.5-20 μM) shows no toxicity on two nonmalignant cell lines. PU-WS13 (15 μM) disrupts the circular architecture of HER2 at the plasma membrane of SKBr3 cells mediated through Grp94. PU-WS13 inhibits Grp94, and the inhibition induces apoptosis in and reduce the viability of HER2 overexpressing breast cancer cells.
6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-11-08 | HY-18680 | 1454619-14-7 | 5mg | 900 | |
2024-11-08 | HY-18680 | 1454619-14-7 | 10mM * 1mLin DMSO | 990 |